Jeremy Hayden Biography and Net Worth

Jeremy commenced his career as a corporate and securities attorney practicing for several international law firms where he specialized in capital markets transactions, M&A and technology transfer transactions.

Since 2012, Jeremy has worked exclusively in senior legal positions for innovative medical device companies, including serving as Assistant General Counsel for Volcano Corporation, General Counsel and Vice President of Business Development for Cytori Therapeutics, Inc. and General Counsel for Endologix, Inc. Jeremy holds a J.D. from University of Michigan Law School and an A.B. in Politics from Princeton University.

What is Jeremy B. Hayden's net worth?

The estimated net worth of Jeremy B. Hayden is at least $1.95 million as of April 6th, 2026. Mr. Hayden owns 369,770 shares of Sight Sciences stock worth more than $1,954,234 as of May 7th. This net worth evaluation does not reflect any other investments that Mr. Hayden may own. Learn More about Jeremy B. Hayden's net worth.

How do I contact Jeremy B. Hayden?

The corporate mailing address for Mr. Hayden and other Sight Sciences executives is 4040 CAMPBELL AVE SUITE 100, MENLO PARK CA, 94025. Sight Sciences can also be reached via phone at 877-266-1144 and via email at [email protected]. Learn More on Jeremy B. Hayden's contact information.

Has Jeremy B. Hayden been buying or selling shares of Sight Sciences?

Within the last three months, Jeremy B. Hayden has sold $48,851.55 in shares of Sight Sciences stock. Most recently, Jeremy B. Hayden sold 13,761 shares of the business's stock in a transaction on Monday, April 6th. The shares were sold at an average price of $3.55, for a transaction totalling $48,851.55. Following the completion of the sale, the insider now directly owns 369,770 shares of the company's stock, valued at $1,312,683.50. Learn More on Jeremy B. Hayden's trading history.

Who are Sight Sciences' active insiders?

Sight Sciences' insider roster includes David Badawi (Founder & Chief Technology Officer), Alison Bauerlein (CFO), Staffan Encrantz (Director), Jeremy Hayden (Chief Legal Officer), James Rodberg (CFO), Jesse Selnick (CFO), and Brenton Taylor (Executive Vice President, Operations and R&D). Learn More on Sight Sciences' active insiders.

Are insiders buying or selling shares of Sight Sciences?

In the last year, insiders at the sold shares 30 times. They sold a total of 307,648 shares worth more than $1,746,086.49. The most recent insider tranaction occured on April, 6th when CFO James Rodberg sold 7,231 shares worth more than $25,670.05. Insiders at Sight Sciences own 30.9% of the company. Learn More about insider trades at Sight Sciences.

Information on this page was last updated on 4/6/2026.